Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
13%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
PSCH
69
HOLDINGS
13%
ALSO IN SBIO
SBIO
92
HOLDINGS
11%
ALSO IN PSCH
SECTOR DRIFT (PSCH minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PSCH |
Weight in SBIO |
Overlap | |
---|---|---|---|---|
KRYSTAL BIOTECH, INC. | 2.8% | 2.5% | 2.5% | |
ALKERMES PLC | 3.0% | 2.4% | 2.4% | |
ARROWHEAD PHARMACEUTICALS, INC. | 2.9% | 2.4% | 2.4% | |
PROTAGONIST THERAPEUTICS, INC. | 2.6% | 2.2% | 2.2% | |
ACADIA PHARMACEUTICALS INC | 1.7% | 1.9% | 1.7% |
PSCH Overweight Relative to SBIO
CORCEPT THERAPEUTICS INC | 5.1% | |
TELEFLEX INC | 3.4% | |
RADNET INC | 3.4% | |
TG THERAPEUTICS INC | 3.1% | |
MERIT MEDICAL SYSTEMS INC | 3.1% | |
GLAUKOS CORP | 3.0% | |
TRANSMEDICS GROUP, INC. | 2.5% | |
ADMA BIOLOGICS, INC. | 2.4% | |
INTEGER HOLDINGS CORPORATION | 2.3% | |
LIGAND PHARMACEUTICALS-CL B | 2.2% |
PSCH Underweight Relative to SBIO
RHYTHM PHARMACEUTICALS, INC. | -3.6% | |
AVIDITY BIOSCIENCES INC | -3.3% | |
CYTOKINETICS INC | -3.1% | |
AXSOME THERAPEUTICS, INC. | -3.1% | |
NUVALENT, INC. CLASS A | -2.8% | |
MERUS N.V. | -2.7% | |
CRINETICS PHARMACEUTICALS INC | -2.4% | |
PTC THERAPEUTICS INC | -2.4% | |
VAXCYTE, INC. | -2.3% | |
ARCELLX, INC. | -2.2% |